<![CDATA[The SPAN survey underscores gaps in schizophrenia care access as new treatments emerge, citing coverage and continuity challenges.]]>
<![CDATA[Interim analysis suggests tazbentetol may regrow synapses, improving cognition and schizophrenia symptoms.]]>
<![CDATA[Study links schizophrenia’s earlier onset to higher genomic deletion CNV burden, showing future potential for personalized care.]]>
<![CDATA[FDA expands Caplyta label to prevent schizophrenia relapse, cutting risk 63% and showing weight-neutral tolerability for sustained long-term stability.]]>
<![CDATA[Chatbot makers face rising lawsuits over suicide, addiction, and psychosis.]]>